Top 30 Biotechnology Angel Investors in LATAM (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Kevin Efrusy
Angel
|
2 | Brazil, United States, Mexico | Series B, Series A, Series C | Software, E-Commerce, FinTech | $6M–$100M |
|
Jessica Livingston
Angel
|
1 | United States, Mexico | Seed, Angel | Medical Device, Education, Health Care | |
|
Ashton Kutcher
Angel
|
1 | United States, Germany, Canada | Seed, Series A, Series B | Software, E-Commerce, Apps | |
|
Dan Knox
Angel
|
1 | Mexico, United States | Seed | Finance, Health Care, Crowdfunding | |
|
Matt Cutts
Angel
|
1 | United States, Canada, Mexico | Seed, Angel, Series A | SaaS, Health Care, Medical | $493k–$2.8M |
|
Allen Miner
Angel
|
1 | Japan, United States, Canada | Seed, Series B | Software, SaaS, Retail | $429k–$20M |
|
Tim Draper
Angel
|
1 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, FinTech, Financial Services | $400k–$50M |
|
Francisco Miranda
Angel
|
1 | Chile | Seed | Biotechnology, Food Processing, Meat and Poultry | |
|
Elizabeth Iorns
Angel
|
1 | United States, Canada, Mexico | Seed, Pre-Seed | Software, SaaS, Health Care | $1.9M–$3M |
|
Eric Urhane
Angel
|
1 | United States, Mexico, Singapore | Seed, Angel | Software, Health Care, Biotechnology | $1.1M–$1.9M |
|
Peter Andersen
Angel
|
1 | Brazil | Series A | Chemical, Biopharma, Biotechnology | |
|
Thomas James
Angel
|
1 | Mexico | Seed | Health Care, Biotechnology, Health Diagnostics | $52k–$1.9M |
|
Martin Torres Cava
Angel
|
1 | Peru | Pre-Seed | Medical, Wellness, Health Care | |
|
Robert Stavis
Angel
|
1 | United States, Canada, Mexico | Series C, Series B, Series A | Financial Services, FinTech, Finance | $3.9M–$126M |
|
Jeff Horing
Angel
|
1 | United States, Israel, Canada | Series B, Series A, Series C | Software, Artificial Intelligence, Information Technology | $8.7M–$210M |
|
Sohail Prasad
Angel
|
1 | United States, France, Mexico | Seed, Series A | Software, Human Resources, Financial Services | $1.1M–$25M |
|
Paul Buchheit
Angel
|
1 | United States, Canada, India | Seed, Series A, Angel | Software, E-Commerce, Health Care | $100k–$13M |
|
Jun Ueki
Angel
|
1 | Argentina | Seed | Biopharma, Biotechnology, Food Processing | |
|
Pablo Pla
Angel
|
1 | Argentina | Seed | Biopharma, Biotechnology, Food Processing | |
|
Fabricio Bloisi
Angel
|
1 | Brazil, Colombia, Argentina | Series A, Seed | Software, Mobile, Internet | $4M–$10M |
|
Eduardo Mufarej
Angel
|
1 | Brazil, Colombia, United States | Seed, Pre-Seed, Series C | EdTech, Biotechnology, Fuel | $1M–$2M |
|
Mat Travizano
Angel
|
1 | Spain, Argentina | Seed, Series A | PaaS, Bitcoin, FinTech | $3.6M–$6.4M |
|
Daniel Gold
Angel
|
1 | Brazil | Pre-Seed | Genetics, Life Science, Biotechnology | |
|
Ignacio Smith
Angel
|
1 | Chile | Seed | Farming, Chemical, Agriculture | |
|
Guilherme Leal
Angel
|
1 | Brazil | Series A | Chemical, Biopharma, Biotechnology | |
|
Geoffrey KALISH
Angel
|
1 | Mexico | Series A | AgTech, Seafood, Biotechnology | |
|
Bob Goodman
Angel
|
1 | United States, Mexico, Germany | Series B, Series C, Series A | Software, SaaS, Enterprise Software | $3.9M–$100M |
|
Steve Zurcher
Angel
|
1 | Argentina | Seed | Biopharma, Biotechnology, Food Processing | |
|
Jason Burke
Angel
|
1 | United States, Mexico | Seed, Pre-Seed, Angel | Health Care, Information Technology, Internet | |
|
Wolfgang Schuch
Angel
|
1 | Chile | Seed | Farming, Chemical, Agriculture | |
| Access all 30 angel investors in LATAM Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Kevin Efrusy is the Co-Founder of The Efrusy Family Foundation and a Partner at Accel. Prior to that, he was the CEO and board member, and co-founder of IronPlanet. He attended Stanford University Graduate School of Business and Stanford University.
Show more...Investment focus
- Industry: Software, E-Commerce, FinTech
- Stage:Series B, Series A, Series C
- Geography: Brazil, United States, Mexico
Investor stats
- Total investments: 72
- Round size: Series A $6M–$30M; Series B $10M–$35M; Series C $11M–$100M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Zubale — Zubale is the critical infrastructure that enables retailers to win in e-commerce. Through our gig workers marketplace and technical integrations we power our clients entire back end e-commerce operations delivering the best fill-rates, on-times and NPS. In the last year, Zubale has completed over 3 million jobs across 90 cities and 16,800 stores.We operate in Mexico, Colombia and Costa Rica and are scaling across Latin America. The Co-Founders Allison Campbell and Sebastian Monroy met during their Harvard MBA and are retail insiders with deep expertise at Walmart and P&G in Latin America, Africa, India and China.
- CAF — We are specialists in combating identity theft and people trying to impersonate others.
- Lemon Energy — A Lemon leva energia solar para a sua empresa, sem obras e com economia anual na conta de luz.
Jessica Livingston is a Co-founding partner. She is also the organizer of Startup School, the big annual startup conference, and the author of Founders at Work, a collection of interviews with successful startup founders.
Show more...Investment focus
- Industry: Medical Device, Education, Health Care
- Stage:Seed, Angel
- Geography: United States, Mexico
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- Balto — Balto, the sports gaming platform made for the casual, everyday fan. We’re thrilled to have you. As a quick intro, we’re Nick Montana, Spencer Cassidy and Joel Karacozoff, three individuals with a passion for gaming and an affinity for bringing people together. As driven co-founders to deliver the best experience, They have set out to create asimple, social and fun gaming interface for all.
- Elpha — Elpha is where women succeed at work together. Become a member to access daily conversations with experts, insider job opportunities, and a lot of women talking candidly about work and life. Plus membership is free!
- Hype and Vice — Hype and Vice combines on-trend fashion with University brands to create officially licensed college apparel women! Cool college apparel to wear for tailgates and gamedays or to lounge around your dorm.
Ashton Kutcher is an actor, investor, entrepreneur, producer and philanthropist.Kutcher has been named one of TIME magazine’s “100 Most Influential People in the World,” as well as being honored by Vanity Fair ‘s “New Establishment List,” which identifies the top 50 of an innovative new breed of buccaneering visionaries, engineering prodigiesand entrepreneurs. Twice, Kutcher was named one of Forbes magazine’s “World’s Most Powerful Celebrities,” as well as one of Fast Company magazine’s “Most Creative People.”Kutcher has been investing in technology for over a decade, both as an angel investor and a founding partner of A-Grade Investments and Sound Ventures. His fund portfolio includes Airbnb, Uber, Flexport, Brex, Robinhood, Bird, Airtable and Affirm among others.Kutcher is also the co-founder of Thorn: Digital Defenders of Children (www.thorn.org). Thorn drives technology innovation to fight the sexual exploitation of children.Kutcher currently stars in the Netflix original series, The Ranch. He also serves as Executive Producer. Until 2015, Kutcher starred in the CBS comedy series Two and a Half Men. The show ranked as the second most-watched comedy on all of network television. Kutcher first gained recognition as Michael Kelso on the Fox series That 70’s Show, and went on to star in a variety of box office hits on the big screen – including What Happens In Vegas with Cameron Diaz, The Guardian with Kevin Costner, No Strings Attached with Natalie Portman and the cult hit Dude, Where’s My Car.Kutcher served as co-creator and producer of MTV's hit series, “Punk'd,” and The CW's reality series “Beauty and the Geek” and “True Beauty.” He has also produced films such as No Strings Attached, Killers and The Butterfly Effect. Additionally, Kutcher co-founded APlus, a digital media company devoted to spreading the message of positive journalism, a kind of storytelling that focuses on our shared humanity. In 2016, APlus was purchased by Chicken Soup for the Soul.
Show more...Investment focus
- Industry: Software, E-Commerce, Apps
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 111
- Lead/follow: no public data
Portfolio highlights
- QD-SOL — QD-SOL uses nanoparticles to produce green hydrogen in half the time.
- Spicewell — Spicewell develops and creates food seasoning products that includes various kinds of micronutrients. It uses modern science to infuse healthy and organic additions to food meals. Spicewell is based in California, USA.
- HempNFibers — Growing hemp. Making a bio fuel to start. Than also an insulation out of it as well. Will look at doing more as company grows. I also know a way to power a whole warehouse by just the plants it’s self but I need funding to get this started. I’m building the transportation side just so I can gain an income to try and get this started.
Dan Knox is one of the founders of Science Exchange, an online marketplace for science experiments. Prior to founding Science Exchange, Dan was Head of Operations at DailyMe, a pioneer in the field of dynamic personalization and predictive content and commerce presentation. Before joining DailyMe, Dan was Head of Economic Analysis within in theStrategy team at a leading commercial television network in the U.K., and a Senior Economist in the Media & Communications group of a global expert services consulting firm.Dan was part of the inaugural Executive MBA class at MIT Sloan School of Management. He also has a Master's degree and a Bachelor's degree in Economics, a Law degree and the Chartered Financial Analyst (CFA) qualification.
Show more...Investment focus
- Industry: Finance, Health Care, Crowdfunding
- Stage:Seed
- Geography: Mexico, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- Experiment — Experiment is an online community and a crowdfunding platform for scientific research. It provides crowdfunding services for scientific research related to categories such as biology, chemistry, computer science, medicine, anthropology, psychology, engineering, and more.The platform provides its services for researchers from over 150institutions and universities around the world. It is in strategic partnerships with Experiment was founded by
Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his
Show more...Investment focus
- Industry: SaaS, Health Care, Medical
- Stage:Seed, Angel, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 11
- Round size: Seed $493k–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Meter Feeder — Easily pay for parking through MeterFeeder
Allen Miner is a founder/General Partner of SunBridge Partners and the founder/CEO of SunBridge Corporation. Allen has significant experience in Internet, enterprise and open-source software, entrepreneurship, and international technology transfer. Allen has been actively involved in each of the firm’s investments resulting in numeroussuccessful IPOs, including salesforce.com, MacroMill, ITMedia and G-Mode, among others. Allen is currently a member of the Board of Directors of salesforce Japan.Allen graduated from Brigham Young University with degrees in Computer Science and Asian Studies. He joined Oracle Corporation in 1986 and was dispatched to Japan, where he founded and helped lead Oracle Japan to a successful IPO on the Japan stock market. Allen returned from Japan in 1996 to serve as Oracle’s Vice President in charge of Linux/Open Source.Allen created SunBridge Corporation in 1999. Allen currently serves on the Boards of several SunBridge portfolio companies and as an advisor to government-affiliated organizations focused on innovation and entrepreneurship. He was appointed to the Board of Directors of the Japan Venture Capital Association upon its founding in 2002.
Show more...Investment focus
- Industry: Software, SaaS, Retail
- Stage:Seed, Series B
- Geography: Japan, United States, Canada
Investor stats
- Total investments: 36
- Round size: Seed $600k–$16M; Series B $429k–$20M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
- Favy — Favy is a platform that enables businesses such as restaurants and beauty salons to launch subscription services.
- BONAVENTURA — BONAVENTURA is a luxury leather goods brand redefining the essence of next-generation luxury under the vision of 'Beyond Luxury,' combining a robust e-commerce foundation with an expanding network of retail stores.Embark on life's journey with BONAVENTURA, where Italian craftsmanship meets timeless design. Blending elegance,functionality, and premium materials, our creations are crafted to bring lasting joy and stand the test of time.The name "BONAVENTURA" and our symbol "Infinity Clover' symbolize good luck and eternal happiness for those who cherish life’s moments.
Tim Draper is the Founding Partner of Draper Associates. He attended Harvard Business School.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 282
- Round size: Seed $400k–$5.9M; Series A $2.5M–$25M; Series B $3M–$50M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- GALY — GALY biocrafts premium cocoa and cotton with quality, traceability, and scalable supply for modern brands.
- Buupass — BuuPass is Kenya's market leader for online bus booking. We enable travelers to reserve seats and make payments in a convenient and timely way. Try BuuPass today!
- Vivoo — Get personalized wellness insights with Vivoo's innovative, science-backed products. Understand your body's needs and take control of your body. Shop now!
CEO of San Pablo Alimentos
Show more...Investment focus
- Industry: Biotechnology, Food Processing, Meat and Poultry
- Stage:Seed
- Geography: Chile
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- BeeTechnology — Biotech StartUp developing active ingredients for food to extend shelf-life, increase food quality and safety, with an organic approach
Elizabeth Iorns is the Co-Founder, President, and CEO of Science Exchange. She previously worked at Y Combinator as a Part-time partner. Elizabeth Iorns attended the University of Auckland.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 6
- Round size: Seed $1.9M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Torch — Transform your organization with Torch's leadership development solutions and drive lasting sustainable change.
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- Enzyme — Enzyme QMS software includes modules for all stages of the product development life cycle from Design Control to CAPA. Our in-house experts are here to back you up! We can guide you through the quality challenges and regulatory submission process. Sign up for a Demo today.
Eric Urhane
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Angel
- Geography: United States, Mexico, Singapore
Investor stats
- Total investments: 5
- Round size: Seed $1.1M–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- X-ZELL — Early, pain-free cancer cell detection
- Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Peter Andersen
Show more...Investment focus
- Industry: Chemical, Biopharma, Biotechnology
- Stage:Series A
- Geography: Brazil
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nintx — Next Innovative Therapeutics involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation.
Thomas James
Show more...Investment focus
- Industry: Health Care, Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: Mexico
Investor stats
- Total investments: 2
- Round size: Seed $52k–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- Miproto —
Doctor specialized in Diagnostic Imaging with more than 25 years of experience, also specialized in Breast Radiology, Occupational Health and Health Management, as well as in technological developments
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Pre-Seed
- Geography: Peru
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Veo365 — Veo365 is a mobile/desktop solution for medical monitoring, occupational health, epidemiological surveillance, health education/prevention and real-time operational standards for companies, organizations, and in general for communities and governments. Their digital solution also integrates wearables and machine learning for a betterhealth diagnostic experience.Veo365 is headquartered in Lima, Peru and was founded in 2019.
Robert Michael Stavis is based out of Larchmont, New York and is the Partner of Bessemer Venture Partners. Robert previously worked at NewSchools Venture Fund as a Director. Robert Stavis attended the University of Pennsylvania.
Show more...Investment focus
- Industry: Financial Services, FinTech, Finance
- Stage:Series C, Series B, Series A
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 35
- Round size: Series A $3.9M–$38M; Series B $9.3M–$126M; Series C $10M–$32M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- LNTS — LNTS has recognized the deficiencies in healthcare and through our proprietary technology and solution, we are making rehabilitation and performance far more efficient for patients, clinicians and providers. LNTSConnect.com
- Flower Company — We sell weed on the internet. Thousands of products delivered overnight throughout California from Humboldt to San Diego
- Bespoke Financial — Bespoke Financial is a licensed lender supporting cannabis companies. They alleviate working capital constraints across the entire cannabis supply chain. Bespoke supports their clients as they scale and grow with unique financing solutions and cannabis business loans.
Jeff Horing is based out of New York, New York and is the Managing Director of Insight Partners. Jeff previously worked at E.M. Warburg, Pincus & Co as a Team Member. Jeff Horing attended the University of Pennsylvania.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 71
- Round size: Series A $8.7M–$125M; Series B $23M–$115M; Series C $42M–$210M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Sweep.io — Sweep transforms metadata into intelligent layer for AI agents, helping teams analyze, build, and scale with clarity. Complexity is holding your team back. Get ahead, and stay ahead, with Sweep.
- Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
- GreenLite Technologies — GreenLite makes getting a construction permit fast, predictable, and transparent. Let the GreenLite Platform handle your permitting needs so you can focus on growing your business.
Sohail is the Founder & CEO of Destiny (D/XYZ).Sohail is also Founder & former Co-CEO of Forge, the stock market for private companies. He has an extensive background in product management, engineering, and business. As an eighteen-year-old, he was among the youngest founders to go through Y Combinator. Over the years, Sohail hasadvised and invested in over 100 startups, including notable startups such as Zenefits and Rappi. He continues to invest actively through S2 Capital, and serves as its Founding Partner. Prior to founding Equidate, Sohail managed mobile product at Zynga. He previously joined mobile advertising firm Chartboost as its second engineering hire, and has held roles at Google and the MIT Media Lab. Sohail was awarded TCU's Texas Youth Entrepreneur of the Year award in 2010, and was later named a Thiel Fellow by the Thiel Foundation. He previously attended Carnegie Mellon University where he studied Electrical & Computer Engineering.
Show more...Investment focus
- Industry: Software, Human Resources, Financial Services
- Stage:Seed, Series A
- Geography: United States, France, Mexico
Investor stats
- Total investments: 12
- Round size: Seed $1.1M–$7M; Series A $11M–$25M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
- Wethenew — Acquistate le vostre autentiche sneakers prodotti streetwear in edizione limitata in modo sicuro e protetto su wethenew.com!
- Series — Series provides full-stack enterprise financial services designed for institutions & enterprises.
Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Series A, Angel
- Geography: United States, Canada, India
Investor stats
- Total investments: 152
- Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$13M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
- BuildForever — BuildForever build products that feel personal, magical and deeply human.
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Jun Ueki is the CEO at Keiretsu Forum Japan.
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Food Processing
- Stage:Seed
- Geography: Argentina
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CarLabs —
- Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Pablo Pla is the Chief Executive Officer of San Miguel. He Previously worked at Ingredion Incorporated as a President and General Manager. Pablo Pla attended Columbia Business School.
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Food Processing
- Stage:Seed
- Geography: Argentina
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Fabricio Bloisi is the CEO of Prosus Group. He previously worked at iFood as a CEO. Fabricio Bloisi attended Harvard Business School.
Show more...Investment focus
- Industry: Software, Mobile, Internet
- Stage:Series A, Seed
- Geography: Brazil, Colombia, Argentina
Investor stats
- Total investments: 13
- Round size: Series A $4M–$10M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- Moova — Moova is a technological platform that captures idle last mile logistic capacity and transforms it into high efficiency and low cost shipping solutions. The platform connects E-Commerce and retail businesses with a fleet of "Moovers" who complete deliveries on their bicycle, motorcycle, car or van to generate an additional source ofincome. Through route optimization software, real-time traceability, flexible warehousing, and analytics, Moova is propelling the nascent E-Commerce industry in Latin America by reimagining the last mile for a sustainable world.
- BioLinker — BioLinker is a production of synthetic biology, protein synthesis kits, and protein.
- Mercadoni — Mercadoni operates an online shopping platform that allows customers to purchase from stores and supermarkets from their homes. It sells groceries, alcoholic beverages, and more. Antonio Nunes, Pedro Freire, Margarita Freitas, Francesco Lanzi and Nicolas Fernández Talice founded Mercadoni in 2015. It has its headquarters in Bogota in Colombia.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Eduardo Mufarej built his career in private equity and education as an investor and entrepreneur. He co-founded and was CEO of Tarpon Investimentos, one of Brazil’s largest independent investment managers. He served on several boards and was Chairman of Somos Educação and Omega Energia Renovável. From 2014 until 2018 Eduardo led the largest k-12company in Latin America, Abril Educação, which he managed until the sale of the company to Kroton Educacional in October 2018. After the sale, Eduardo created Renova, a project focused on selecting and training a new generation of leaders in Brazilian politics. Since its creation, the program has supported and trained over 2000 individuals in Brazil, helping to elect 176 of its students. This effort awarded Eduardo the prize Brazilian Entrepreneur of the Year in 2018. In early 2020, Eduardo co-founded Galena, a company that supports and trains individuals for their first jobs. Eduardo is a member of the advisory board of the Wilson Institute, in Washington, DC, of the Yale University SOM Council of Global Advisors and a fellow at Stanford’s Graduate School of Education. He is the author of the book Jornada Improvável (Unlikely Journey, 2021).
Show more...Investment focus
- Industry: EdTech, Biotechnology, Fuel
- Stage:Seed, Pre-Seed, Series C
- Geography: Brazil, Colombia, United States
Investor stats
- Total investments: 4
- Round size: Seed $1M–$2M
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
- HUNTY — HUNTY is a platform that help people find jobs by connecting them with world class mentors who prepare them for the job search process. And people only pay when they get hired.
- Alicerce — Alicerce is a social impact platform designed to support middle-class education. It offers an educational solution, focused on what is most important and promotes the social ascension of Brazilian families.The company is driven by a mission to provide a successful opportunity for all young Brazilians through quality education.Alicerce wasfounded in 2017 and is headquartered in Sao Paulo, Brazil.
Mat Travizano is the Founder & Chairman at GranData.
Show more...Investment focus
- Industry: PaaS, Bitcoin, FinTech
- Stage:Seed, Series A
- Geography: Spain, Argentina
Investor stats
- Total investments: 3
- Round size: Seed $3.6M–$6.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
- Reloadly — Send gift cards, airtime & payouts globally with one API. Scalable, instant, developer-friendly platform for rewards and incentives.
- SenseiNode — We drive the decentralization of the blockchain ecosystem in Latin America with a simple, scalable and secure node management platform.
Daniel Gold
Show more...Investment focus
- Industry: Genetics, Life Science, Biotechnology
- Stage:Pre-Seed
- Geography: Brazil
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- gen-t — Gen-t is a platform capable of providing the map of genomic research. Gen-t was founded in 2021 and was headquartered in Sao Paulo, Brazil.
Ignacio Smith
Show more...Investment focus
- Industry: Farming, Chemical, Agriculture
- Stage:Seed
- Geography: Chile
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Botanical Solutions — BSI produces plant-based biofungicides for sustainable agriculture & advanced botanical materials for the gold standard vaccine adjuvant QS-21
Guilherme Leal is the founder of Arapyaú.
Show more...Investment focus
- Industry: Chemical, Biopharma, Biotechnology
- Stage:Series A
- Geography: Brazil
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Nintx — Next Innovative Therapeutics involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation.
Mr. Kalish is a Partner & Chief Operating Officer at Aquiline Capital Partners.Previously, Mr. Kalish was also the Founder and Managing Director at Venturion Capital. He has served on the boards of numerous financial services companies in Europe and the US. He holds a history degree from Columbia and a masters degree in public policy fromHarvard.
Show more...Investment focus
- Industry: AgTech, Seafood, Biotechnology
- Stage:Series A
- Geography: Mexico
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Robert Goodman is a general partner at Goodman served as a director at he joined Bessemer Venture Partners. He has also worked at Goodman holds a bachelor’s degree in arts from
Show more...Investment focus
- Industry: Software, SaaS, Enterprise Software
- Stage:Series B, Series C, Series A
- Geography: United States, Mexico, Germany
Investor stats
- Total investments: 35
- Round size: Series A $3.9M–$17M; Series B $10M–$40M; Series C $15M–$100M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Fuze, an 8x8 company — Fuze provides a unified, cloud communication software for enterprises that includes call center, phone system and video conferencing solutions.
- Electric — Electric is a new way to manage your SMBs IT and Security, transforming the way you manage cybersecurity, devices, employees and apps with one place for everything, no tech skills required and all synced with your HR system.
- Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Steve Zurcher
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Food Processing
- Stage:Seed
- Geography: Argentina
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Michroma — Michroma is a biotech platform producing natural ingredients in a sustainable, scalable, and cost-effective way. We are using synthetic biology to unleash the potential of filamentous fungi and develop proprietary strains capable of producing high-performance ingredients in bioreactors.
Jason Burke is the Co-founder, Managing Director, and Investor of TBD Angels and the VP of Strategy and Business Development of Xandr. Prior to that, he was the Chief Strategy Officer for clypd, a Boston-based startup building an advertising technology platform exclusively for the TV industry and designed to empower media companies with actionablesales tools. In his role, Burke focuses on a forward-looking platform and business strategy, corporate development, partnerships, and management of clypd's strategic commercial deals.As one of the first employees at clypd, Burke spent over 3 years as VP, Product leading the product & operations teams in bringing innovative products to the $180B television advertising market. Prior to clypd, Burke spent six years building ad technology products for online video at ScanScout and Tremor Video where he had responsibility for product management, technical strategy and operations efforts.Jason is a leader with the unique experience of working with executive customer teams and internal product development/engineering groups to drive business while also solving software and implementation challenges with internal and external technical teams. He is also a frequent contributor to industry publications and participant on advertising technology and media conference presentations and panels. Jason holds several software patents focused on inventions in advertising technology and media.Jason is also an investor in early-stage companies across several verticals. He feels privileged to invest in and collaborate with talented founding teams seeking to change the world with innovative products & businesses.Jason is based in Boston and has degrees in Computer Science and Engineering Psychology from Tufts University.
Show more...Investment focus
- Industry: Health Care, Information Technology, Internet
- Stage:Seed, Pre-Seed, Angel
- Geography: United States, Mexico
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Eva — Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks. The company's wearable device is equipped with tactile sensors which are designed to map the surface of the breast and surrounding areas, allowing women to keep a track on the changes in breast temperature, size, and weight, with the help ofbiosensors inside the cup which constantly monitors information.
- Wrangle — Wrangle organizes requests in your Slack team channel. Automatically assign approvals and tasks for your team to follow up and track their status.
- WorkAround — WorkAround is the accurate, scalable solution for adding human input to your data using an untapped workforce of domain experts.WorkAround's platform enables simple, quick annotation of data. Anything from classifying expenses into tax codes, annotating breast tissue to identify regions of interest, to identifying drug combinations fromclinical trial reports. We have the domain experts and a platform to facilitate a simple, secure processing of customer data and annotations.Companies that using WorkAround services not only save time and get quality service, but are also contributing to a more socially just and productive world where talent knows no boundaries, opportunity doesn’t ask for status, and work is rewarded with fair pay.
Wolfgang Schuch
Show more...Investment focus
- Industry: Farming, Chemical, Agriculture
- Stage:Seed
- Geography: Chile
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Botanical Solutions — BSI produces plant-based biofungicides for sustainable agriculture & advanced botanical materials for the gold standard vaccine adjuvant QS-21
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Angel Investors in LATAM investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 angel investors investing in LATAM Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!